TreeWAS – Variant ID: rs480688

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
Chapter VI Diseases of the nervous system	1.000	0.000
# Top node	1.000	0.000
G90-G99 Other disorders of the nervous system	0.999	0.001
G50-G59 Nerve, nerve root and plexus disorders	0.999	0.001
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.999	0.001
Chapter XIV Diseases of the genitourinary system	0.997	0.003
N00-N08 Glomerular diseases	0.996	0.004
G55 Nerve root and plexus compressions in diseases classified elsewhere	0.994	0.006
Chapter XX External causes of morbidity and mortality	0.993	0.007
G95 Other diseases of spinal cord	0.989	0.011
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.989	0.011
T36-T50 Poisoning by drugs, medicaments and biological substances	0.988	0.012
M20-M25 Other joint disorders	0.987	0.013
N20-N23 Urolithiasis	0.984	0.016
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.984	0.016
G55.3 Nerve root and plexus compressions in other dorsopathies	0.980	0.020
N20 Calculus of kidney and ureter	0.977	0.023
M25 Other joint disorders, not elsewhere classified	0.972	0.028
N03 Chronic nephritic syndrome	0.968	0.032
Chapter II Neoplasms	0.968	0.032
N40-N51 Diseases of male genital organs	0.967	0.033
G55.1 Nerve root and plexus compressions in intervertebral disk disorders	0.966	0.034
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.960	0.040
M25.7 Osteophyte	0.959	0.041
G50 Disorders of trigeminal nerve	0.956	0.044
G93 Other disorders of brain	0.952	0.048
N05 Unspecified nephritic syndrome	0.951	0.049
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.950	0.050
N03.9 Unspecified	0.949	0.051
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.948	0.052
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.947	0.053
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.946	0.054
N41 Inflammatory diseases of prostate	0.940	0.060
M86-M90 Other osteopathies	0.938	0.062
Y42.5 Other oestrogens and progestogens	0.937	0.063
C71 Malignant neoplasm of brain	0.936	0.064
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.934	0.066
N20.0 Calculus of kidney	0.929	0.071
N41.1 Chronic prostatitis	0.929	0.071
G95.9 Disease of spinal cord, unspecified	0.928	0.072
M25.8 Other specified joint disorders	0.927	0.073
N20.1 Calculus of ureter	0.926	0.074
G80-G83 Cerebral palsy and other paralytic syndromes	0.926	0.074
M21 Other acquired deformities of limbs	0.925	0.075
N02 Recurrent and persistent haematuria	0.920	0.080
C71.1 Frontal lobe	0.920	0.080
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.918	0.082
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.917	0.083
M40-M43 Deforming dorsopathies	0.914	0.086
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.913	0.087
T40.2 Other opioids	0.912	0.088
C45 Mesothelioma	0.912	0.088
G50.0 Trigeminal neuralgia	0.906	0.094
M25.75 Osteophyte (Pelvic region and thigh)	0.903	0.097
G91 Hydrocephalus	0.901	0.099
M25.76 Osteophyte (Lower leg)	0.900	0.100
M89 Other disorders of bone	0.896	0.104
M35 Other systemic involvement of connective tissue	0.894	0.106
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.893	0.107
N05.9 Unspecified	0.892	0.108
N48 Other disorders of penis	0.886	0.114
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.885	0.115
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.882	0.118
Y60-Y69 Misadventures to patients during surgical and medical care	0.880	0.119
N48.8 Other specified disorders of penis	0.876	0.124
M24 Other specific joint derangements	0.873	0.127
G81 Hemiplegia	0.872	0.128
N50 Other disorders of male genital organs	0.872	0.128
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.872	0.128
G95.2 Cord compression, unspecified	0.872	0.128
X10-X19 Contact with heat and hot substances	0.868	0.132
T50.9 Other and unspecified drugs, medicaments and biological substances	0.867	0.133
G95.1 Vascular myelopathies	0.867	0.133
G70-G73 Diseases of myoneural junction and muscle	0.867	0.133
Y51 Drugs primarily affecting the autonomic nervous system	0.862	0.137
N20.2 Calculus of kidney with calculus of ureter	0.862	0.138
M21.3 Wrist or foot drop (acquired)	0.861	0.139
G93.6 Cerebral oedema	0.861	0.139
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.855	0.145
M00-M03 Infectious arthropathies	0.854	0.145
T20-T25 Burns and corrosions of external body surface, specified by site	0.854	0.146
C45.0 Mesothelioma of pleura	0.852	0.148
C15-C26 Malignant neoplasms of digestive organs	0.852	0.148
G56 Mononeuropathies of upper limb	0.850	0.150
M60-M63 Disorders of muscles	0.846	0.154
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.846	0.154
W50-W64 Exposure to animate mechanical forces	0.844	0.156
G95.8 Other specified diseases of spinal cord	0.844	0.156
T42.4 Benzodiazepines	0.844	0.156
G93.9 Disorder of brain, unspecified	0.844	0.156
M41 Scoliosis	0.840	0.160
C25 Malignant neoplasm of pancreas	0.837	0.163
G81.9 Hemiplegia, unspecified	0.834	0.166
X60-X84 Intentional self-harm	0.833	0.167
C64-C68 Malignant neoplasms of urinary tract	0.833	0.167
C49 Malignant neoplasm of other connective and soft tissue	0.830	0.170
M25.84 Other specified joint disorders (Hand)	0.829	0.171
M25.3 Other instability of joint	0.828	0.172
N02.8 Other	0.826	0.174
S50-S59 Injuries to the elbow and forearm	0.825	0.175
G00-G09 Inflammatory diseases of the central nervous system	0.822	0.178
Q80-Q89 Other congenital malformations	0.818	0.182
M89.0 Algoneurodystrophy	0.816	0.184
M21.37 Wrist or foot drop (acquired) (Ankle and foot)	0.816	0.184
C25.9 Pancreas, unspecified	0.815	0.185
N50.8 Other specified disorders of male genital organs	0.815	0.185
M25.72 Osteophyte (Upper arm)	0.815	0.185
G56.2 Lesion of ulnar nerve	0.813	0.187
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.812	0.188
C32 Malignant neoplasm of larynx	0.812	0.188
T51 Toxic effect of alcohol	0.811	0.189
T39.1 4-Aminophenol derivatives	0.806	0.194
N40 Hyperplasia of prostate	0.804	0.196
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.802	0.198
Q50-Q56 Congenital malformations of genital organs	0.800	0.200
G55.0 Nerve root and plexus compressions in neoplastic disease	0.797	0.203
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.796	0.204
G93.0 Cerebral cysts	0.793	0.207
M41.9 Scoliosis, unspecified	0.792	0.208
N04 Nephrotic syndrome	0.791	0.209
Y41 Other systemic anti-infectives and antiparasitics	0.790	0.209
G50.9 Disorder of trigeminal nerve, unspecified	0.790	0.210
G94 Other disorders of brain in diseases classified elsewhere	0.789	0.211
S90-S99 Injuries to the ankle and foot	0.789	0.211
Y42.0 Glucocorticoids and synthetic analogs	0.788	0.212
G35-G37 Demyelinating diseases of the central nervous system	0.788	0.212
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.787	0.213
Y47 Sedatives, hypnotics and antianxiety drugs	0.786	0.214
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.783	0.217
M25.86 Other specified joint disorders (Lower leg)	0.782	0.218
Y54.3 Benzothiadiazine derivatives	0.782	0.218
M89.3 Hypertrophy of bone	0.780	0.220
M80-M85 Disorders of bone density and structure	0.775	0.225
C45.7 Mesothelioma of other sites	0.774	0.226
G93.8 Other specified disorders of brain	0.772	0.228
Y42.7 Androgens and anabolic congeners	0.771	0.229
Y48 Anaesthetics and therapeutic gases	0.770	0.230
N02.9 Unspecified	0.769	0.231
N05.1 Focal and segmental glomerular lesions	0.768	0.232
T13 Other injuries of lower limb, level unspecified	0.767	0.233
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.764	0.236
G93.5 Compression of brain	0.763	0.237
M05-M14 Inflammatory polyarthropathies	0.760	0.240
M35.0 Sicca syndrome [Sjogren]	0.760	0.240
T15-T19 Effects of foreign body entering through natural orifice	0.760	0.240
C71.9 Brain, unspecified	0.759	0.241
G82 Paraplegia and tetraplegia	0.759	0.241
G20-G26 Extrapyramidal and movement disorders	0.758	0.242
M21.1 Varus deformity, not elsewhere classified	0.757	0.243
M25.87 Other specified joint disorders (Ankle and foot)	0.757	0.243
T51.0 Ethanol	0.757	0.243
Chapter X Diseases of the respiratory system	0.757	0.243
N23 Unspecified renal colic	0.757	0.243
M21.2 Flexion deformity	0.756	0.244
G52 Disorders of other cranial nerves	0.755	0.245
G53 Cranial nerve disorders in diseases classified elsewhere	0.755	0.245
M24.5 Contracture of joint	0.755	0.245
G97.8 Other postprocedural disorders of nervous system	0.755	0.245
C67 Malignant neoplasm of bladder	0.755	0.245
Y60.0 During surgical operation	0.754	0.246
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.754	0.246
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.753	0.247
Y53 Agents primarily affecting the gastro-intestinal system	0.750	0.250
C32.1 Supraglottis	0.750	0.250
T00-T07 Injuries involving multiple body regions	0.750	0.250
T36 Poisoning by systemic antibiotics	0.749	0.251
M41.99 Scoliosis, unspecified (Site unspecified)	0.748	0.252
G91.8 Other hydrocephalus	0.747	0.253
T80-T88 Complications of surgical and medical care, not elsewhere classified	0.746	0.254
J30-J39 Other diseases of upper respiratory tract	0.746	0.254
C25.0 Head of pancreas	0.745	0.255
V20-V29 Motorcycle rider injured in transport accident	0.744	0.255
T40.4 Other synthetic narcotics	0.744	0.256
M25.83 Other specified joint disorders (Forearm)	0.744	0.256
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.742	0.258
G51 Facial nerve disorders	0.738	0.262
C01 Malignant neoplasm of base of tongue	0.738	0.262
M45-M49 Spondylopathies	0.737	0.263
M34 Systemic sclerosis	0.737	0.263
M00 Pyogenic arthritis	0.736	0.264
N05.2 Diffuse membranous glomerulonephritis	0.735	0.265
V40-V49 Car occupant injured in transport accident	0.735	0.265
Q38-Q45 Other congenital malformations of the digestive system	0.734	0.266
M25.77 Osteophyte (Ankle and foot)	0.734	0.266
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.732	0.268
X10 Contact with hot drinks, food, fats and cooking oils	0.731	0.269
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.731	0.269
S10-S19 Injuries to the neck	0.731	0.269
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.730	0.270
Y46 Antiepileptics and anti-Parkinsonism drugs	0.730	0.270
T42.0 Hydantoin derivatives	0.730	0.270
W55 Bitten or struck by other mammals	0.729	0.271
T79-T79 Certain early complications of trauma	0.728	0.272
G70 Myasthenia gravis and other myoneural disorders	0.726	0.274
X50-X57 Overexertion, travel and privation	0.725	0.275
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.724	0.276
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.724	0.276
M35.3 Polymyalgia rheumatica	0.722	0.278
M89.09 Algoneurodystrophy (Site unspecified)	0.719	0.281
C71.4 Occipital lobe	0.719	0.281
N08 Glomerular disorders in diseases classified elsewhere	0.719	0.281
M35.8 Other specified systemic involvement of connective tissue	0.718	0.282
G91.0 Communicating hydrocephalus	0.717	0.283
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
G98 Other disorders of nervous system, not elsewhere classified	0.716	0.284
G92 Toxic encephalopathy	0.716	0.284
T88 Other complications of surgical and medical care, not elsewhere classified	0.716	0.284
V10-V19 Pedal cyclist injured in transport accident	0.716	0.284
N07 Hereditary nephropathy, not elsewhere classified	0.714	0.286
N06 Isolated proteinuria with specified morphological lesion	0.714	0.286
N01 Rapidly progressive nephritic syndrome	0.714	0.286
N00 Acute nephritic syndrome	0.714	0.286
C06 Malignant neoplasm of other and unspecified parts of mouth	0.714	0.286
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts	0.712	0.288
M43 Other deforming dorsopathies	0.712	0.288
C15 Malignant neoplasm of oesophagus	0.712	0.288
Y35-Y36 Legal intervention and operations of war	0.712	0.288
Y10-Y34 Event of undetermined intent	0.712	0.288
X85-X99 Assault	0.712	0.288
X30-X39 Exposure to forces of nature	0.712	0.288
X00-X09 Exposure to smoke, fire and flames	0.712	0.288
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.712	0.288
W75-W84 Other accidental threats to breathing	0.712	0.288
W65-W74 Accidental drowning and submersion	0.712	0.288
V98-V99 Other and unspecified transport accidents	0.712	0.288
V95-V97 Air and space transport accidents	0.712	0.288
V90-V94 Water transport accidents	0.712	0.288
V70-V79 Bus occupant injured in transport accident	0.712	0.288
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.712	0.288
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.712	0.288
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.712	0.288
V01-V09 Pedestrian injured in transport accident	0.712	0.288
Y00-Y09 Assault	0.711	0.289
T14 Injury of unspecified body region	0.710	0.290
T33-T35 Frostbite	0.709	0.291
T26-T28 Burns and corrosions confined to eye and internal organs	0.709	0.291
M33 Dermatopolymyositis	0.709	0.291
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.708	0.291
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.708	0.291
T41 Poisoning by anaesthetics and therapeutic gases	0.708	0.291
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.708	0.291
C71.0 Cerebrum, except lobes and ventricles	0.708	0.292
X12 Contact with other hot fluids	0.708	0.292
M36 Systemic disorders of connective tissue in diseases classified elsewhere	0.708	0.292
M32 Systemic lupus erythematosus	0.708	0.292
G54 Nerve root and plexus disorders	0.708	0.292
G91.1 Obstructive hydrocephalus	0.707	0.293
G71 Primary disorders of muscles	0.705	0.295
N22 Calculus of urinary tract in diseases classified elsewhere	0.705	0.295
Y59 Other and unspecified vaccines and biological substances	0.705	0.295
Y58 Bacterial vaccines	0.705	0.295
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.705	0.295
Y50 Central nervous system stimulants, not elsewhere classified	0.705	0.295
M25.78 Osteophyte (Other)	0.705	0.295
M25.0 Haemarthrosis	0.705	0.295
T11 Other injuries of upper limb, level unspecified	0.705	0.295
C45.9 Mesothelioma, unspecified	0.703	0.297
N48.5 Ulcer of penis	0.703	0.297
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.702	0.298
V80-V89 Other land transport accidents	0.701	0.299
S91 Open wound of ankle and foot	0.701	0.299
M60 Myositis	0.701	0.299
T40.6 Other and unspecified narcotics	0.700	0.300
Q85 Phakomatoses, not elsewhere classified	0.700	0.300
Y49 Psychotropic drugs, not elsewhere classified	0.700	0.300
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.700	0.300
C12 Malignant neoplasm of pyriform sinus	0.699	0.301
M88 Paget's disease of bone [osteitis deformans]	0.699	0.301
M87 Osteonecrosis	0.698	0.302
G06 Intracranial and intraspinal abscess and granuloma	0.697	0.302
M25.2 Flail joint	0.697	0.303
M25.1 Fistula of joint	0.697	0.303
W20-W49 Exposure to inanimate mechanical forces	0.697	0.303
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.696	0.304
G56.3 Lesion of radial nerve	0.696	0.304
M25.71 Osteophyte (Shoulder region)	0.695	0.305
M25.37 Other instability of joint (Ankle and foot)	0.695	0.305
X40-X49 Accidental poisoning by and exposure to noxious substances	0.695	0.305
N03.8 Other	0.694	0.306
N03.7 Diffuse crescentic glomerulonephritis	0.694	0.306
N03.6 Dense deposit disease	0.694	0.306
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.694	0.306
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.694	0.306
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.694	0.306
N03.2 Diffuse membranous glomerulonephritis	0.694	0.306
N03.1 Focal and segmental glomerular lesions	0.694	0.306
N03.0 Minor glomerular abnormality	0.694	0.306
C40-C41 Malignant neoplasms of bone and articular cartilage	0.694	0.306
N51 Disorders of male genital organs in diseases classified elsewhere	0.694	0.306
N44 Torsion of testis	0.694	0.306
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.692	0.308
M30 Polyarteritis nodosa and related conditions	0.692	0.308
M86 Osteomyelitis	0.691	0.309
J80-J84 Other respiratory diseases principally affecting the interstitium	0.690	0.310
Y42.9 Other and unspecified hormone antagonists	0.688	0.311
Y42.4 Oral contraceptives	0.688	0.311
Y42.2 Antithyroid drugs	0.688	0.311
Y42.1 Thyroid hormones and substitutes	0.688	0.311
N49 Inflammatory disorders of male genital organs, not elsewhere classified	0.688	0.312
T20 Burn and corrosion of head and neck	0.688	0.312
M25.79 Osteophyte (Site unspecified)	0.688	0.312
M25.73 Osteophyte (Forearm)	0.688	0.312
M25.70 Osteophyte (Multiple sites)	0.688	0.312
G60 Hereditary and idiopathic neuropathy	0.687	0.313
C49.3 Connective and soft tissue of thorax	0.686	0.314
G50.8 Other disorders of trigeminal nerve	0.685	0.315
G50.1 Atypical facial pain	0.685	0.315
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.685	0.315
C71.8 Overlapping lesion of brain	0.684	0.316
M21.5 Acquired clawhand, clubhand, clawfoot and clubfoot	0.684	0.316
G91.9 Hydrocephalus, unspecified	0.683	0.316
M89.8 Other specified disorders of bone	0.683	0.317
J35 Chronic diseases of tonsils and adenoids	0.683	0.317
G93.7 Reye's syndrome	0.682	0.318
N05.8 Other	0.682	0.318
N05.7 Diffuse crescentic glomerulonephritis	0.682	0.318
N05.6 Dense deposit disease	0.682	0.318
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.682	0.318
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.682	0.318
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.682	0.318
N05.0 Minor glomerular abnormality	0.682	0.318
Q89 Other congenital malformations, not elsewhere classified	0.682	0.318
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.681	0.319
T40.8 Lysergide [LSD]	0.681	0.319
T40.7 Cannabis (derivatives)	0.681	0.319
T40.5 Cocaine	0.681	0.319
T40.3 Methadone	0.681	0.319
T40.1 Heroin	0.681	0.319
T40.0 Opium	0.681	0.319
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.680	0.320
C70 Malignant neoplasm of meninges	0.680	0.320
M89.04 Algoneurodystrophy (Hand)	0.680	0.320
C77.9 Lymph node, unspecified	0.680	0.320
M25.88 Other specified joint disorders (Other)	0.679	0.321
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.679	0.321
C46 Kaposi's sarcoma	0.679	0.321
T56 Toxic effect of metals	0.679	0.321
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.678	0.322
T39.4 Antirheumatics, not elsewhere classified	0.678	0.322
T39.2 Pyrazolone derivatives	0.678	0.322
Q00-Q07 Congenital malformations of the nervous system	0.677	0.323
C71.3 Parietal lobe	0.676	0.323
C32.9 Larynx, unspecified	0.675	0.325
M41.96 Scoliosis, unspecified (Lumbar region)	0.675	0.325
N41.8 Other inflammatory diseases of prostate	0.674	0.326
N41.3 Prostatocystitis	0.674	0.326
N41.2 Abscess of prostate	0.674	0.326
C09 Malignant neoplasm of tonsil	0.672	0.328
C71.7 Brain stem	0.671	0.329
C71.6 Cerebellum	0.671	0.329
C71.5 Cerebral ventricle	0.671	0.329
G24 Dystonia	0.671	0.329
S56 Injury of muscle and tendon at forearm level	0.671	0.329
T88.7 Unspecified adverse effect of drug or medicament	0.671	0.329
M24.54 Contracture of joint (Hand)	0.670	0.330
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.670	0.330
Q35-Q37 Cleft lip and cleft palate	0.670	0.330
Q30-Q34 Congenital malformations of the respiratory system	0.670	0.330
T43.0 Tricyclic and tetracyclic antidepressants	0.669	0.331
T42.1 Iminostilbenes	0.669	0.331
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.668	0.332
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.667	0.333
M62 Other disorders of muscle	0.666	0.334
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.665	0.335
S50 Superficial injury of forearm	0.665	0.335
M25.89 Other specified joint disorders (Site unspecified)	0.665	0.335
M25.82 Other specified joint disorders (Upper arm)	0.665	0.335
M25.80 Other specified joint disorders (Multiple sites)	0.665	0.335
C67.9 Bladder, unspecified	0.664	0.336
M96 Postprocedural musculoskeletal disorders, not elsewhere classified	0.663	0.337
M21.9 Acquired deformity of limb, unspecified	0.663	0.337
M21.8 Other specified acquired deformities of limbs	0.663	0.337
M21.7 Unequal limb length (acquired)	0.663	0.337
M24.7 Protrusio acetabuli	0.663	0.337
C49.0 Connective and soft tissue of head, face and neck	0.663	0.337
N41.0 Acute prostatitis	0.662	0.338
G35 Multiple sclerosis	0.662	0.338
M46 Other inflammatory spondylopathies	0.662	0.338
M24.4 Recurrent dislocation and subluxation of joint	0.661	0.338
M24.8 Other specific joint derangements, not elsewhere classified	0.661	0.339
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.661	0.339
C21 Malignant neoplasm of anus and anal canal	0.661	0.339
N02.7 Diffuse crescentic glomerulonephritis	0.660	0.340
N02.6 Dense deposit disease	0.660	0.340
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.660	0.340
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.660	0.340
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.660	0.340
N02.2 Diffuse membranous glomerulonephritis	0.660	0.340
N02.1 Focal and segmental glomerular lesions	0.660	0.340
N02.0 Minor glomerular abnormality	0.660	0.340
J39 Other diseases of upper respiratory tract	0.660	0.340
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts	0.659	0.341
G90 Disorders of autonomic nervous system	0.659	0.341
T50.8 Diagnostic agents	0.658	0.342
T50.7 Analeptics and opioid receptor antagonists	0.658	0.342
T50.6 Antidotes and chelating agents, not elsewhere classified	0.658	0.342
T50.5 Appetite depressants	0.658	0.342
T50.4 Drugs affecting uric acid metabolism	0.658	0.342
T50.3 Electrolytic, caloric and water-balance agents	0.658	0.342
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.658	0.342
T50.1 Loop [high-ceiling] diuretics	0.658	0.342
T50.0 Mineralocorticoids and their antagonists	0.658	0.342
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.657	0.342
T42.5 Mixed antiepileptics, not elsewhere classified	0.657	0.342
T42.3 Barbiturates	0.657	0.342
T42.2 Succinimides and oxazolidinediones	0.657	0.342
N48.9 Disorder of penis, unspecified	0.657	0.342
N25-N29 Other disorders of kidney and ureter	0.657	0.343
M07 Psoriatic and enteropathic arthropathies	0.657	0.343
Q20-Q28 Congenital malformations of the circulatory system	0.656	0.344
C32.0 Glottis	0.656	0.344
M42 Spinal osteochondrosis	0.655	0.345
C04 Malignant neoplasm of floor of mouth	0.655	0.345
G62 Other polyneuropathies	0.654	0.346
T45.0 Antiallergic and antiemetic drugs	0.654	0.346
C45.2 Mesothelioma of pericardium	0.653	0.346
C45.1 Mesothelioma of peritoneum	0.653	0.346
Y52 Agents primarily affecting the cardiovascular system	0.653	0.347
J30 Vasomotor and allergic rhinitis	0.653	0.347
S59 Other and unspecified injuries of forearm	0.653	0.347
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.652	0.348
M89.37 Hypertrophy of bone (Ankle and foot)	0.652	0.348
M00.9 Pyogenic arthritis, unspecified	0.651	0.349
G91.2 Normal-pressure hydrocephalus	0.651	0.349
M35.7 Hypermobility syndrome	0.651	0.349
G59 Mononeuropathy in diseases classified elsewhere	0.650	0.349
X20-X29 Contact with venomous animals and plants	0.650	0.349
J80 Adult respiratory distress syndrome	0.650	0.350
G93.4 Encephalopathy, unspecified	0.649	0.351
G83 Other paralytic syndromes	0.648	0.352
S99 Other and unspecified injuries of ankle and foot	0.647	0.353
G91.3 Posttraumatic hydrocephalus, unspecified	0.646	0.354
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.645	0.355
M89.9 Disorder of bone, unspecified	0.645	0.355
N70-N77 Inflammatory diseases of female pelvic organs	0.645	0.355
X58-X59 Accidental exposure to other and unspecified factors	0.644	0.356
T13.1 Open wound of lower limb, level unspecified	0.644	0.356
M85 Other disorders of bone density and structure	0.644	0.356
Y47.1 Benzodiazepines	0.644	0.356
M24.1 Other articular cartilage disorders	0.643	0.357
M02 Reactive arthropathies	0.643	0.357
G93.1 Anoxic brain damage, not elsewhere classified	0.643	0.357
J36 Peritonsillar abscess	0.643	0.357
M89.6 Osteopathy after poliomyelitis	0.642	0.357
M89.5 Osteolysis	0.642	0.357
M89.4 Other hypertrophic osteo-arthropathy	0.642	0.357
M89.2 Other disorders of bone development and growth	0.642	0.357
M89.1 Epiphyseal arrest	0.642	0.357
C69 Malignant neoplasm of eye and adnexa	0.642	0.358
M40 Kyphosis and lordosis	0.642	0.358
Q54 Hypospadias	0.642	0.358
Q83 Congenital malformations of breast	0.641	0.359
M35.9 Systemic involvement of connective tissue, unspecified	0.641	0.359
M35.6 Relapsing panniculitis [Weber-Christian]	0.641	0.359
M35.5 Multifocal fibrosclerosis	0.641	0.359
M35.4 Diffuse (eosinophilic) fasciitis	0.641	0.359
M35.2 Behcet's disease	0.641	0.359
T09 Other injuries of spine and trunk, level unspecified	0.640	0.359
T12.X1 Fracture of lower limb, level unspecified (open)	0.640	0.359
T12.X0 Fracture of lower limb, level unspecified (closed)	0.640	0.359
T12 Fracture of lower limb, level unspecified	0.640	0.359
T10.X1 Fracture of upper limb, level unspecified (open)	0.640	0.359
T10.X0 Fracture of upper limb, level unspecified (closed)	0.640	0.359
T10 Fracture of upper limb, level unspecified	0.640	0.359
T08.X1 Fracture of spine, level unspecified (open)	0.640	0.359
T08.X0 Fracture of spine, level unspecified (closed)	0.640	0.359
T08 Fracture of spine, level unspecified	0.640	0.359
M24.2 Disorder of ligament	0.640	0.360
M80 Osteoporosis with pathological fracture	0.640	0.360
C30 Malignant neoplasm of nasal cavity and middle ear	0.639	0.361
T22.0 Burn of unspecified degree of shoulder and upper limb, except wrist and hand	0.638	0.362
M89.38 Hypertrophy of bone (Other)	0.637	0.362
S54 Injury of nerves at forearm level	0.637	0.363
C02 Malignant neoplasm of other and unspecified parts of tongue	0.637	0.363
M25.9 Joint disorder, unspecified	0.637	0.363
M91-M94 Chondropathies	0.637	0.363
M25.33 Other instability of joint (Forearm)	0.636	0.364
M06 Other rheumatoid arthritis	0.636	0.364
N04.2 Diffuse membranous glomerulonephritis	0.635	0.364
N48.3 Priapism	0.635	0.365
T65 Toxic effect of other and unspecified substances	0.634	0.366
T62 Toxic effect of other noxious substances eaten as food	0.634	0.366
T61 Toxic effect of noxious substances eaten as seafood	0.634	0.366
T60 Toxic effect of pesticides	0.634	0.366
T59 Toxic effect of other gases, fumes and vapours	0.634	0.366
T57 Toxic effect of other inorganic substances	0.634	0.366
T54 Toxic effect of corrosive substances	0.634	0.366
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.634	0.366
T52 Toxic effect of organic solvents	0.634	0.366
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.634	0.366
T58 Toxic effect of carbon monoxide	0.634	0.366
T55 Toxic effect of soaps and detergents	0.634	0.366
C67.2 Lateral wall of bladder	0.634	0.366
C16 Malignant neoplasm of stomach	0.634	0.366
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.634	0.366
W00-W19 Falls	0.634	0.366
M21.26 Flexion deformity (Lower leg)	0.634	0.366
Q74 Other congenital malformations of limb(s)	0.633	0.367
X10.0 Home	0.633	0.367
J35.1 Hypertrophy of tonsils	0.633	0.367

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations